OraSure Technologies Net Profit Margin 2010-2025 | OSUR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

OraSure Technologies net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

OraSure Technologies net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$220.2B
Boston Scientific (BSX)	$157B
Stryker (SYK)	$154B
EssilorLuxottica (ESLOY)	$136.6B
Medtronic (MDT)	$119.2B
Lonza Group Ag (LZAGY)	$50.3B
Haleon (HLN)	$44.4B
ResMed (RMD)	$40.3B
GE HealthCare Technologies (GEHC)	$35.5B
Agilent Technologies (A)	$34.1B
Terumo (TRUMY)	$25.8B
Koninklijke Philips (PHG)	$25.2B
Insulet (PODD)	$20.4B
Zimmer Biomet Holdings (ZBH)	$19.3B
Baxter (BAX)	$15B
Smith & Nephew SNATS (SNN)	$13.9B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7.2B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.9B
AtriCure (ATRC)	$1.6B
Acuren (TIC)	$1.4B